KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Historical Holders from Q3 2022 to Q3 2025

Symbol
KALA on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
9.82M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1.73M
Holdings value
$2.65M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
21
Number of buys
13
Number of sells
-13
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OXFORD FINANCE LLC 16.5% $1.22M 1.62M OXFORD FINANCE LLC 25 Nov 2025
BAKER BROS. ADVISORS LP 9.99% 0% $11.4M 745K 0% Baker Bros. Advisors LP 02 Oct 2025
SR ONE CAPITAL MANAGEMENT, LLC 4.6% -15% $5.26M -$1.02M 344K -16.3% SR One Capital Management, LLC 14 Oct 2025
ADAR1 Capital Management, LLC 4.91% $1.27M 299K ADAR1 Capital Management, LLC 31 Dec 2024
Point72 Asset Management, L.P. 0% -95.7% $393 -$717K 257 -99.9% Point72 Asset Management, L.P. 30 Sep 2025

Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.73M $2.65M -$8.49M $1.53 21
2025 Q2 3.64M $17.3M -$2.66M $4.76 28
2025 Q1 4.14M $23.7M +$3.69M $5.73 26
2024 Q4 3.46M $24M +$9.35M $6.94 29
2024 Q3 2.12M $12.1M +$82.5K $5.70 26
2024 Q2 2.09M $14.8M +$10.4M $7.09 27
2024 Q1 617K $4.88M +$714K $7.97 27
2023 Q4 526K $3.68M +$62.1K $7.00 23
2023 Q3 514K $4.57M +$1.12M $8.90 24
2023 Q2 381K $5.56M +$893K $14.59 26
2023 Q1 319K $4.81M -$2.07M $15.05 22
2022 Q4 324K $12.4M +$12.3M $38.15 27
2022 Q3 90.5K $20K +$20K $0.22 1